• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. BONE SCREW SELF-TAPPING; PROSTHESIS, HIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. BONE SCREW SELF-TAPPING; PROSTHESIS, HIP Back to Search Results
Catalog Number 00625006525
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); Bursitis (4832)
Date of Event 12/16/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).D10: cat: 110010263, lot: 65175033, g7 osseoti multihole 50mm d.Cat: 0087750320, lot: 3073979, bioloxâ® delta, ceramic femoral head/ the customer has indicated that the product will not be returned to zimmer biomet for investigation, as it remains implanted.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event or Problem Description
It was reported that approximately three years post-implantation, a patient from a study reported moderate pain and was diagnosed with trochanteric bursitis and given a cortisone injection.All implants remain.Attempts have been made and no further information has been provided.
 
Event or Problem Description
It was reported that approximately two years post-op, the patient reported moderate pain and was diagnosed with trochanteric bursitis and given a cortisone injection.A second injection was required at the three-year post-op follow up due to recurrent trochanteric bursitis and pain.All implants remain.Attempts have been made and no further information has been provided.
 
Additional Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.The following sections were updated: b5; b7; e1; g3; h2 the investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event or Problem Description
No further information is available at the time of this report.
 
Additional Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.The following sections were updated: d4; g3; h2; h4; h6; h10.Product has not been evaluated as it has been determined the event is not related to device.Root cause of the reported event is not device related.Bursitis is the inflammation or irritation of the bursae (the fluid filled sac that cushions the joint) and is typically caused by repetitive motion, overuse, and pressure to the bursae.Bursitis is a very common condition that can impact any of the joints and can last for a short duration or years.Symptoms the patient can experience include pain, tenderness, swelling, stiffness, decrease in movement, and/or redness at or around the joint that is involved.Conservative treatment consists of over the counter (otc) medications pain relievers and anti-inflammatories, rest, ice, elevation, and applying pressure wraps.If conservative treatments fail, physical therapy, aspiration, arthroscopy, or steroid injections may be necessary.The complaint indicates that postop bursitis developed and required medical intervention for treatment.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Additional Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.The following sections were updated: b5; g3; h2.The following sections were corrected: b3 event date corrected to unknown date in 2023.For initial diagnosis of trochanteric bursitis; d5.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event or Problem Description
It was reported that approximately two years post-op, the patient reported moderate pain and was diagnosed with trochanteric bursitis and given a cortisone injection.A second injection was required at the three-year post-op follow up due to recurrent trochanteric bursitis and pain.A third injection and topical anti-inflammatory cream was given six-months later for moderate pain.All implants remain.Attempts have been made and no further information has been provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BONE SCREW SELF-TAPPING
Common Device Name
PROSTHESIS, HIP
Manufacturer (Section D)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer (Section G)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key21784998
Report Number0001822565-2025-00903
Device Sequence Number8591451
Product Code LPH
UDI-Device Identifier00889024119819
UDI-Public(01)00889024119819(17)310623(10)J7051238
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
K921308
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 08/14/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Catalogue Number00625006525
Device Lot NumberJ7051238
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/12/2025
Supplement Date Received by Manufacturer04/07/2025
06/16/2025
07/23/2025
Initial Report FDA Received Date04/07/2025
Supplement Report FDA Received Date05/01/2025
06/23/2025
08/14/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/23/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11 NARRATIVE.
Outcome Attributed to Adverse Event Other;
Patient Age48 YR
Patient SexFemale
Patient Weight83 KG
Patient RaceWhite
-
-